1,179 Shares in The Clorox Company (NYSE:CLX) Purchased by Crews Bank & Trust

Crews Bank & Trust acquired a new stake in shares of The Clorox Company (NYSE:CLX) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 1,179 shares of the company’s stock, valued at approximately $191,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Catalyst Capital Advisors LLC acquired a new position in Clorox in the 3rd quarter worth approximately $54,000. Los Angeles Capital Management LLC boosted its position in shares of Clorox by 5.6% in the third quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after buying an additional 10,149 shares during the period. Advisors Asset Management Inc. boosted its position in shares of Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after buying an additional 9,037 shares during the period. Natixis Advisors LLC grew its holdings in shares of Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after buying an additional 4,839 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in Clorox by 1.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after buying an additional 13,038 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Price Performance

NYSE CLX opened at $160.28 on Friday. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The stock’s 50-day moving average is $163.15 and its two-hundred day moving average is $158.01. The firm has a market cap of $19.84 billion, a P/E ratio of 55.85, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period last year, the business earned $0.49 EPS. The firm’s revenue was up 27.0% compared to the same quarter last year. On average, analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.04%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.04%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CLX. JPMorgan Chase & Co. raised their price objective on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a research report on Thursday, January 16th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $155.00 to $157.00 in a report on Tuesday, January 7th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Evercore ISI cut their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $156.07.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.